No, I know it's not, but that's where people in Africa get the drugs, and mainly across the world. That's why PEPFAR is getting the drugs from India, but it relies on things that are not on patent, so it is relying on companies all over the world to supply it with the drugs. This is a large...whatever it is, 800 million people, or 36% of the GDP. This is going to affect its ability to get generic drugs.
On April 20th, 2016. See this statement in context.